PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,020,367 | +1557.9% | 1,422,794 | +1242.7% | 0.00% | – |
| Q2 2023 | $121,862 | +42809.2% | 105,967 | -60.5% | 0.00% | – |
| Q1 2023 | $284 | -92.3% | 268,372 | -89.0% | 0.00% | -100.0% |
| Q4 2022 | $3,701 | -99.0% | 2,434,605 | +1291.4% | 0.00% | – |
| Q3 2022 | $371,000 | -90.2% | 174,976 | -93.8% | 0.00% | -100.0% |
| Q2 2022 | $3,784,000 | -63.7% | 2,824,171 | -42.8% | 0.00% | -66.7% |
| Q1 2022 | $10,410,000 | +34.7% | 4,933,435 | +136.8% | 0.01% | +50.0% |
| Q4 2021 | $7,730,000 | +386.5% | 2,083,448 | +554.1% | 0.00% | +300.0% |
| Q3 2021 | $1,589,000 | -39.1% | 318,508 | -15.9% | 0.00% | -50.0% |
| Q1 2021 | $2,609,000 | +581.2% | 378,715 | +246.0% | 0.00% | – |
| Q3 2020 | $383,000 | -76.7% | 109,457 | -66.7% | 0.00% | -100.0% |
| Q2 2020 | $1,641,000 | -51.6% | 328,893 | -67.0% | 0.00% | -75.0% |
| Q1 2020 | $3,390,000 | – | 997,181 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |